Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“Non-toxic concentrations (5-20 microM) of chloroquine, quinine, quinidine , and primaquine potentiated the toxicity of doxorubicin in a concentration-dependent manner.”
“The result demonstrated that verapamil, quinidine , tamoxifen, and oligomycin had an additive effect on the cytotoxicity of adriamycin and vinblastine against RCC8701 and RCC8701/ADR800 tumor cells.”
Journal of the National Cancer Institute • 1994 | View Paper
“Results highlight the utility of quinidine as a drug response modulator in a schedule-dependent manner to potentiate the cytotoxicity of ADR and MITO and warrants further studies into a possible role of quinidine to increase the chemotherapeutic efficacy of antineoplastic drugs in the clinics.”
“The enhancing effect of quinidine (7.5 micrograms/mL) on sensitivity to ADR was statistically significant only in the group with high MDR1 RNA levels.”
“In the presence of quinidine , the biliary excretion of doxorubicin was reduced significantly; however, doxorubicinol recovery in bile was not altered.”
“ Quinidine and GF120918 inhibit the transport of P-gp substrates, including doxorubicin.”
“ Quinidine was associated with a decrease in doxorubicin canalicular egress, doxorubicinol formation, and other doxorubicinol pathways.”
“Substances that are substrates for P-glycoprotein, such as verapamil, vinblastine, vincristine and quinidine , significantly increased doxorubicin concentrations in LLC-PK1 cells.”
The Journal of pharmacology and experimental therapeutics • 1998 | View Paper
“A non-toxic concentration of quinidine (5 microM) enhanced the DNA biosynthesis inhibition induced by ADR (55 to 65%) and MITO (37 to 44%) in P388/ADR cells, indicating reversal of resistance, while in P388/S cells only a minimal increase in DNA biosynthesis inhibition was observed.”
“ Quinidine enhanced the cytotoxicity of both ADR and MITO in P388/S and P388/ADR cells, as assessed by the decrease in color intensity of formazan crystal in the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay.”
“ Quinidine increased the cellular levels of ADR by 53 to 126% in P388/ADR cells in vitro, but failed to indicate such elevated levels of cellular ADR in P388/S cells.”
“The combination of quinidine at doses of 50 to 100 mg/kg significantly potentiated the antitumor activity of ADR and MITO in P388/ADR bearing mice, whereas the potentiation of ADR and MITO antitumor response was lower in P388/S bearing mice.”